-Background -Surgical resection is the mainstay of treatment for colorectal cancer with curative intent. Aim -To evaluate the postoperative results of laparoscopic and laparotomic colorectal resections for colorectal cancer. Methods -A retrospective study of a series of 189 patients. The descriptive variables were age and gender, and for outcome were type of resection, number of lymph nodes resected, free margins, the need for colostomy, complications, operative time and hospital stay. They were analyzed using the chi-square, In both pathways, the average number of removed lymph nodes was greater than 12, but laparotomy enabled, more frequently, the resection of 12 or more nodes (p = 0.012). No patient had surgical margins involved, but laparotomy allowed a greater number of patients with a margin greater than 5 cm from the tumor (p = 0.036). Increased number of patients treated by open surgery were hospitalized for more than seven days (p <0.001). There were no statistically significant differences regarding the need for ostomies, complications and mortality. Conclusions -The laparoscopic approach was as safe and effective as laparotomy in the treatment of colorectal cancer, and was associated with increased operative time, shorter hospital stay and less morbidity. ABCDDV/847RESUMO -Racional -A ressecção cirúrgica é o principal elemento do tratamento do câncer colorretal com intenção curativa. Objetivo -Analisar os resultados pós-operatórios de ressecções colorretais laparotômicas e videolaparoscópicas por câncer colorretal. Métodos -Estudo retrospectivo de uma série de 189 pacientes operados. As variáveis descritivas foram idade e gênero, e as de desfecho foram tipo de ressecção, número de linfonodos ressecados, margens, necessidade de ostomia, complicações, tempo operatório e tempo de internação. Elas foram analisadas por meio dos testes do Qui-quadrado, t de student e Mann-Whitney, com nível de significância <0,05. Resultados -Dos 189 pacientes operados, 110 preencheram os critérios de inclusão, sendo 75 (68,2%) operados por cirurgia aberta e 35 (31,8%) por via videolaparoscópica. O cólon sigmóide foi o local mais comum de apresentação da neoplasia e a retossigmoidectomia foi a ressecção colorretal mais realizada, e mais por via aberta (p=0,042). A taxa de conversão foi de 7,9% (3/38). Os pacientes operados por via aberta apresentaram em 81,5% tempo operatório inferior a 180 minutos (p<0,001). Em ambas as vias, o número médio de linfonodos ressecados foi maior que 12, porém a técnica laparotômica permitiu, com maior frequência, a ressecção de 12 ou mais linfonodos (p=0,012). Nenhum paciente apresentou margem cirúrgica comprometida, mas a laparotomia permitiu um maior número de pacientes com margem maior que 5 cm em relação ao tumor (p=0,036). Maior número de pacientes tratados por via aberta esteve internado por tempo superior a sete dias (p<0,001). Não foram encontradas diferenças estatisticamente significantes quanto à necessidade de ostomias, complicações e mortalidade hospitalar. Conclusões -A a...
Background: Deep infiltrating colorectal endometriosis may severely affect the quality of life and fertility of patients. Although segmental resection is a therapeutic option that provides positive outcomes in the management of symptoms, its functional effects are still unproven. Aim: Assess the late impact of the laparoscopic approach in treating deep infiltrating endometriosis with segmental colorectal resection. Methods: Prospective case series of 46 patients submitted to laparoscopic treatment of deep infiltrating endometriosis with segmental colorectal resection between 2013 and 2016. Fertility, gynecological and bowel symptoms were assessed at the preoperative period and at three and 12 months (or more) after the procedure. Results: Preoperative interview assessed the prevalence of infertility (45.6%), gynecological (87%) and intestinal (80.4%) symptoms. At the third month after the procedure a significant reduction in the prevalence of gynecological symptoms (p<0,001), tenesmus (p=0,001) and dysquesia (p=0,002) was observed. After a period of 12 months or more following the procedure a significant reduction in the prevalence persisted for dysmenorrhea (p=0,001), deep dyspareunia (p=0,041), chronic pelvic pain (p=0,011) and dysquesia (p=0,001), as compared to the preoperative period. Total pregnancy rate was 57.1% and spontaneous pregnancy 47.6%. Conclusion: The treatment of deep infiltrating endometriosis using segmental colorectal resection has provided early and late relief of gynecological and bowel symptoms. The outcomes also indicate a positive impact on the fertility of infertile patients.
BackgroundFew studies evaluated the association between nutritional disorders, quality of life and weight loss in patients undergoing bariatric surgery.AimTo identify nutritional changes in patients undergoing bariatric surgery and correlate them with weight loss, control of comorbidities and quality of life. MethodA prospective cohort, analytical and descriptive study involving 59 patients undergoing bariatric surgery was done. Data were collected preoperatively at three and six months postoperatively, evaluating nutritional aspects and outcomes using BAROS questionnaire. The data had a confidence interval of 95%.ResultsThe majority of patients was composed of women, 47 (79.7%), with 55.9% of the series with BMI between 40 to 49.9 kg/m². In the sixth month after surgery scores of quality of life were significantly higher than preoperatively (p<0.05) and 27 (67.5 %) patients had comorbidities resolved, 48 (81.3 %) presented BAROS scores of very good or excellent. After three and six months of surgery 16 and 23 presented some nutritional disorder, respectively. There was no relationship between the loss of excess weight and quality of life among patients with or without nutritional disorders.ConclusionsNutritional disorders are uncommon in the early postoperative period and, when present, have little or no influence on quality of life and loss of excess weight.
BACKGROUND: Intragastric balloon (IGB) use is indicated for patients whose BMI precludes the option of bariatric surgery or who need to lose weight prior to undergoing surgery. It is a minimally invasive procedure and currently there are two main models of IGBs in use, the non-adjustable intragastric balloon (NIB), implanted for six months, and the adjustable intragastric balloon (AIB), implanted for up to 12 months. OBJECTIVE: Analyze clinical characteristics between patients receiving non-adjustable gastric balloon and the adjustable (prolonged implantation) intragastric balloon. METHODS: This was a cross-sectional study of 470 patients diagnosed as obese or overweight who had balloon implantation from October 2011 to July 2018. The associations between percentage excess weight loss versus clinical and demographic variables were calculated using the chi-squared test. Independent samples were submitted to the Student’s t test to determine the quantitative variables, with a confidence interval of 95%. Calculation of excess weight was based on an estimated ideal weight that would correspond to a BMI of 24.99 kg/m2. RESULTS: A total of 414 patients completed the treatment achieving an average total body weight loss (%TBWL) of 15.4±7 with the NIB and 15.5±9.6 with the AIB. Overweight patients achieved higher excess weight loss (%EWL) values using AIBs (157.2±82.5) and obese patients did so with NIB use (56±29.7). Women achieved higher %EWL values (65.6±62.2) than men (48±27.1). Individuals who attended >4 consultations with a nutritionist (60.8%) achieved TBWL >18%. All of those P-values were <0.001. CONCLUSION: Obese individuals and women registered the greatest weight losses. Overweight patients achieved greater losses using AIB and obese patients did so using NIBs. NIB use was associated with higher EWL percentages. Nutritional accompaniment had a positive impact on the %TBWL.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.